DoD buys vaccines

The Department of Defense plans to buy vaccine technology for protection against three bacterial infectious diseases. Syntiron LLC who through a sister company manufactures animal vaccines has been working with the Federal Government to develop and adapt this technology for human vaccines. The tree targeted diseases are anthrax, a variant of the plague and a highly mortal bacterial infection spread through water. The contract is worth almost $4 M and reflects the greater emphasis on protective measures against WMD.

See the press release at PharmaLive.com.

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter